pd 98059 has been researched along with am 630 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertolotto, M; Braunersreuther, V; Burger, F; Capettini, L; da Silva, RF; Dallegri, F; Di Marzo, V; Galan, K; Gayet-Ageron, A; Kuzmanovic, K; Lenglet, S; Mach, F; Montecucco, F; Pagano, S; Palombo, D; Pane, B; Pelli, G; Pende, A; Pilet, L; Piscitelli, F; Quintao, S; Roux-Lombard, P; Santos, RA; Spinella, G; Steffens, S; Stergiopulos, N; Viviani, GL; Vuilleumier, N | 1 |
| Hinz, B; Peters, K; Ramer, R; Salamon, A; Schmuhl, E | 1 |
2 other study(ies) available for pd 98059 and am 630
| Article | Year |
|---|---|
The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques.
Topics: Aged; Animals; Aorta, Thoracic; Cannabinoids; Carotid Artery, Internal; Carotid Stenosis; Case-Control Studies; Female; Flavonoids; Humans; Indoles; Male; MAP Kinase Signaling System; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Neutrophils; Phosphorylation; Plaque, Atherosclerotic; Protein Kinase Inhibitors; Receptor, Cannabinoid, CB2; Tumor Necrosis Factor-alpha | 2012 |
Increase of mesenchymal stem cell migration by cannabidiol via activation of p42/44 MAPK.
Topics: Cannabidiol; Cannabinoids; Cell Differentiation; Cell Movement; Cells, Cultured; Cyclohexanes; Flavonoids; Gene Expression Regulation, Enzymologic; Humans; Indoles; Mesenchymal Stem Cells; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Osteoblasts; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB2; Resorcinols | 2014 |